Predictors of exercise-induced bronchoconstriction in subjects with mild asthma

doi:10.21203/rs.3.rs-116834/v2

Download PDF

Research

Predictors of exercise-induced bronchoconstriction in subjects with mild asthma

https://doi.org/10.21203/rs.3.rs-116834/v2

This work is licensed under a CC BY 4.0 License

Journal Publication

published 14 Aug, 2021

Read the published version in Allergy, Asthma & Clinical Immunology →

You are reading this latest preprint version

Background Physical effort is a stimulus capable of triggering airway obstruction in asthmatics, the so-called exercise-induced bronchoconstriction in asthma (EIBa). This study was performed in subjects with mild persistent asthma, aiming to find predictors for developing EIBa.

Methods In 20 subjects with mild asthma, measurements of baseline functional respiratory parameters and airways responsiveness by a methacholine challenge were obtained on the first day. The day after, a maximal, symptom-limited incremental cardiopulmonary exercise test (CPExT) was performed, with subsequent, repeated maneuvers of maximal full forced expiration to monitor the FEV 1 change at 1,3,5,7,10 and 15 minutes after the end of exercise.

Results 19 subjects completed the two-days protocol. No functional parameters both at rest and during effort were useful to predict EIBa after stopping exercise. In asthmatics with EIBa, mean Inspiratory Capacity (IC) did not increase with increasing ventilatory requirements during CPExT, because 6 of them (50%) displayed dynamic pulmonary hyperinflation (DH), as documented by their progressive increase of end-expiratory lung volume. This subgroup, showing earlier post-exercise FEV 1 fall, had significantly lower forced mean expiratory flow between 25% and 75% of forced vital capacity (FEF 25-75% ) at rest (p<0.05) and higher airways responsiveness, expressed as PD 20 FEV 1 (p<0.05) as compared with other asthmatics with EIBa.

Conclusions No functional respiratory parameters seem to predict EIBa in mild asthmatics. However, in those with EIBa, a subgroup developed DH during exercise, and this was associated with a baseline reduced forced expiratory flow-rates at lower lung volumes and higher airway hyperresponsiveness, suggesting a prominent small airways impairment.

Allergy & Immune Disorders

Immunology

exercise-induced asthma

dynamic hyperinflation

airways hyperresponsiveness

small airway disease.

In patients suffering from bronchial asthma, physical exertion may acutely trigger airway obstruction leading to chest tightness, wheezing, dry cough, and dyspnea, that cease spontaneously with time or more quickly after treatment, namely bronchodilators with rapid onset of action (1).

This picture is now called exercise-induced bronchoconstriction in asthma (EIBa) (2), and although sometimes may be the prominent clinical manifestation of asthma, is enough to impair lifestyle and quality of life, especially among children, teens, young adults, and athletes (1,3). A high prevalence of asthmatics can be affected by EIBa (4,5,6).

Usually, airflow obstruction occurs soon after the end of exercise mainly due to both osmotic and thermal mechanisms (2,7,8), but sometimes may develop during exercise, limiting the subjects’ physical performance (9).

Adequate treatment of underlying airway inflammation and, if needed, pre-treatment with fast short-acting (rarely fast long-acting) beta-2 selective agonists, or leukotriene-receptor antagonists is effective to control and prevent this event (10).

It would be useful to identify simple functional predictors of EIBa, mainly in asthmatic young people, in order to implement useful strategies to avoid bronchoconstriction and related symptoms after or even during exercise, as much as possible.

In subjects with persistent mild asthma suspected for EIBa, the study aimed to identify functional parameters, either at rest or during exercise, predictors of effort-related airflow obstruction.

Subjects

This prospective study was performed at the Respiratory Medicine Unit of Spedali Civili University-Hospital of Brescia, Italy, from July 2018 to February 2019. To be included in the study, the subjects had to be aged 18-40 years and never smokers, have had a diagnosis of mild persistent asthma, according to GINA guidelines (11), supported by clinical judgment and objective measurements of lung function, including a positive methacholine challenge test for airway hyperresponsiveness and stable conditions for at least 8 weeks under usual treatment. Asthmatic subjects with other respiratory diseases and medical comorbidities were excluded from the study. The participants were recruited only if in the past they reported or were reported to have episodes suspected for effort-related acute respiratory symptoms.

Study design

Functional respiratory tests

In the morning of the first day, after an 8-hour washout from short-acting bronchodilators, 48-hour washout from long-acting bronchodilators, and 4-week washout from any inhaled corticosteroids (ICS) or oral anti-cysteinyl leukotrienes, each subject performed in the first-day spirometry (BIOMEDIN Instruments, Padua, Italy) wearing a nose clip and breathing through a flanged mouthpiece. Slow vital capacity (VC) and inspiratory capacity (IC) were measured twice using a bell spirometer at rest in sitting position. At least three acceptable and reproducible maximal full expiratory maneuvers were performed to measure forced vital capacity (FVC), maximal expiratory volume in the first second (FEV₁), and maximal forced expiratory flows ad different lung volumes.

Lung volumes were measured with a pressure-constant plethysmograph (BIOMEDIN Instruments, Padua, Italy). During the procedure, patients panted at a 0.7 Hertz frequency. Three acceptable tracings of mouth pressure versus box volume changes were averaged to achieve a final measurement of functional residual capacity (FRC). Total lung capacity (TLC) and residual volume (RV) were computed subsequently. In each circumstance, the best values were collected for analysis. All tests were performed according to the ERS-ATS recommendations (12). Predicted values of lung function parameters were those proposed by the European Community for Coal and Steel (13).

In the late morning, each subject performed a challenge test for measuring nonspecific, direct airway responsiveness using doubling doses of methacholine inhaled by dosimeter (MEFAR, Brescia, Italy). The tests were stopped just after more than 20% reduction of FEV₁ from baseline (saline inhalation) to calculate airway sensitivity as PD₂₀FEV₁.

The second day, in the late morning, each subject underwent a symptom-limited, incremental cardiopulmonary exercise test by computer-driven cyclo-ergometer with the ramping protocol (15 watts increment per minute) at a pedaling frequency of 50-60 per minute (CPExT). This protocol always achieved 80-90 % of the predicted maximum heart rate towards the end of exercise and maintained it for few minutes. At rest and regular intervals of 2 minutes during exercise, the subjects were asked to inspire maximally toward total lung capacity (TLC) to obtain their inspiratory capacity (IC) that was measured off-line and expressed as % of TLC, at 33%, 66% and 99% of the peak workload.

At the end of the effort, repeated full forced expiratory maneuvers were requested to obtain maximal flow-volume curves to measure FEV₁ at 1-3-5-7-10-15 minutes after stopping exercise. A FEV₁ fall greater than 10% of FEV₁ measured before starting exercise was considered as indicative of EIBa.

Statistics

Unless specified otherwise, data are expressed as the mean ± standard deviation. Comparing the functional variables between groups was performed according to the Student’s unpaired t-test or the Mann-Whitney U test if the normal distribution could not be assumed. Statistical significance was accepted if p ≤ 0.05. Statistical analyses were performed using Graph Pad Prism 6.0 (Graph Pad Software, La Jolla, CA) and SPSS 23.00 (IBM, Armonk, NY).

Twenty asthmatic subjects were enrolled in the study. One subject refused CPExT and was excluded from the analysis. Among 19 subjects, 7 (37%) did not show EIBa with a DFEV₁max from baseline (made equal to 100) amounting to 97±6% (absolute change -2.6±2.0%), while 12 (63%) had EIBa with a DFEV₁max from baseline (made equal to 100), amounting to 85±6% (absolute change -16.2±6.7%).

Anthropometric and baseline functional data of the 19 patients of the study are shown in Table 1, all together and divided into 2 groups according to the presence or absence of EIBa. No significant differences emerged between the 2 groups. The mean duration of asthma was 11±3 yr, with no significant difference between the two groups. All subjects were treated with inhaled corticosteroids that were withdrawn 4 weeks before the study and 7 (2 in the group without EIBa) with long-acting beta-2 agonists on top.

Mean data obtained at the peak of CPExT are presented in Table 2 with the IC values at different prefixed percent levels of the maximal effort, again in all subjects, and divided into 2 groups: those without EIBa, and those with EIBa. Not significantly different values of main variables of interest at peak exercise were found between the 2 groups. However, while mean IC progressively increased throughout exercise in asthmatics without EIBa, mean IC slightly decreased during exercise in asthmatics with EIBa.

The end-inspiratory (EILV as %TLC) and end-expiratory (EELV as % TLC) lung volume changes during exercise are illustrated in Fig.1, panel a and b for the non-EIBa and EIBa groups, respectively, indicating a possible exertional dynamic pulmonary hyperinflation (DH) in asthmatics with EIBa.

However, looking at the individual measurements of IC during exercise in asthmatics with EIBa, 6 out of 12 (50%) displayed a progressive, significant IC decrease and EELV (as %TLC) increase (EIBa subgroup 2), reflecting a noticeable DH. In contrast, the other 6 (EIBa subgroup 1) had a normal lung mechanics behavior during the effort, similar to that shown by the asthmatics without EIBa (see Table 3 and Fig. 1, panel d and c).

The other different variable at the peak of exercise between the two subgroups with EIBa was the respiratory rate, much higher in the EIBa subgroup 2 (41.3+6.5 vs. 33.3+6.4, p<0.05).

By comparing the lung function measurements at rest between these two subgroups of asthmatics with EIBa, the only different parameter resulted in the maximal mean expiratory flow-rate between 25% and 75% of forced vital capacity (FEF_25-75%), which was significantly reduced in the subgroup with DH (EIA subgroup 2) (64±16%pred. vs. 91±10%pred., respectively; p<0.05), suggesting a greater structural involvement (inflammation/remodeling) of the small airways in these subjects (Fig. 2, a). Patients with EIBa subgroup 2 showed significantly lower FEF25-75% values than patients without EIBa (64±16%pred. vs. 88±22%pred., respectively; p<0.05).

Interestingly, PD₂₀FEV₁ was markedly lower in the subgroup with EIBa and with DH (geometric mean 55 (33-261) mcg vs. 389 (101-683) mcg; p<0.05), partly explained by larger ventilation heterogeneity that is a marker of peripheral airway impairment (Fig. 2,b). The PD₂₀FEV₁ value of the group without EIA was not different from the PD₂₀FEV₁ value observed in EIBa subgroup 2, amounting to 57 (40-273) mcg vs. 55 (33-261) mcg, respectively.

No differences were found between the non-EIBa group and EIBa subgroup 1 concerning baseline pulmonary function tests (including FEF_25-75%) and parameters obtained during CPExT.

Finally, the post-exercise fall in FEV₁, albeit more rapid and pronounced in the EIBa patients with DH during exercise (EIBa subgroup 2) as compared with those with EIBa without DH during exercise (EIBa subgroup 1), was not significantly different between them (Fig. 3).

The main findings of the study are the following. No functional parameter either at rest or during exercise was significantly different and able to distinguish in a population of subjects with mild persistent asthma who would have had EIBa and who not. In contrast with asthmatics without EIBa, IC did not increase during exercise in those with EIBa, and some of them (in our series 50%) developed DH during exercise with earlier FEV₁ fall after stopping it. This subgroup of asthmatics with EIBa with DH during exercise (subgroup 2) showed a significant reduction of FEF_25-75%at rest and higher airway responsiveness to methacholine, suggesting a more extensive structural and functional involvement of small airways.

We did not find any respiratory functional parameters at rest, useful to predict the occurrence of exercise-induced bronchoconstriction in relatively young asthmatics with similar history and severity of disease (mild persistent asthma). Also, during exercise, albeit patients developing EIBa had slightly lower mean peak values of workload and oxygen uptake, there were no significant differences in average between the two groups.

Asthmatics with EIBa, however, showed a distinct functional behavior during exercise characterized by the absence of EELV reduction (Fig. 1) with a subgroup developing DH, as witnessed by the progressive IC decrease, that was associated with significantly reduced forced expiratory flows at lower lung volumes at baseline and higher airway responsiveness.

In the presence of normal FEV₁ and FVC, reduced FEF_25-75%strongly suggest an increased up-stream resistance in these asthmatics’ small airways that, favoring a larger ventilation heterogeneity, may in part explain the higher airway hyperresponsiveness we observed concurrently (14).

The baseline reduced expiratory flow reserve at lower lung volumes, corresponding to the tidal volume range, may promote tidal expiratory flow limitation (EFL) when the ventilatory requirements increase during exertion. This possibility that is the occurrence of EFL was elegantly demonstrated by Kosmas and coworkers some years ago, using the negative expiratory pressure technique, in a large percentage of subjects suffering from asthma of different severity, from intermittent or mild to severe, but without EIBa, during symptom-limited incremental bicycle exercise test (15). Interestingly, asthmatics who developed EFL during exercise had a lower baseline FEF_25-75%and FEF_75%than those without EFL.

An increment of airway resistance throughout the exercise observed in some asthmatics (15,16), especially with EIBa (9, 17,18), can markedly increase this possibility.

In these circumstances breathing at higher operative lung volumes allows to escape tidal EFL or have minimal EFL and continue exercising but at the expense of progressive DH (19).

Therefore, these indices such as FEF_25-75%and PD₂₀FEV₁, easily obtained at rest, could explain why some asthmatics with EIBa may have symptoms also during effort linked to the development of DH that might limit their exercise tolerance and maximal performance because of its associated mechanical constraints.

In the future would be interesting by using FOT to measure parameters of respiratory system resistance (Rrs5-Rrs20 difference) and reactance (Xrs5 or AX), exploring small and peripheral airway mechanical properties, to confirm this hypothesis in asthmatics suffering from EIBa who begin to have mechanical lung impairment and related symptoms also during effort (20).

Higher airway hyperresponsiveness (i.e., higher sensitivity as PD₂₀FEV₁) can ensue from deeper epithelial damage associated with either greater airway inflammation or abnormal neurogenic control or both, and this condition may certainly induce a worse functional impairment of small airways. Concurrently, larger ventilation heterogeneity sustained by a marked small airway involvement might also explain higher airway hyperresponsiveness (13). We cannot discriminate between these two different mechanisms that, however, could coexist in this subgroup of asthmatics with EIBa.

This study is limited by the relatively small number of subjects and possibly by choice of the exercise challenge that is less than optimal for induction of EIBa, but needful to measure the operational lung volumes dynamic changes. However, we were able to elicit EIBa in more than 60% of the subjects recruited for suspicious exertional symptoms. Finally, we do not think that the absence of a matched control group could invalidate our findings’ meaning.

None of the routine functional parameters measured at rest and during exercise can distinguish among mild asthmatics those who will develop EIBa or not.

However, in some mild asthmatics with EIBa, dynamic hyperinflation can occur during exercise, possibly limiting their exercise tolerance and performance. Such as unfavorable mechanical constraint is associate with significantly decreased forced mean flow-rates at lower lung volumes at rest and higher airway hyper-responsiveness, suggesting a more profound involvement of small airways in these subjects. That may explain why some asthmatics with EIBa become symptomatic during effort and not only after stopping it.

EIBa = Exercise-induced bronchoconstriction in asthma

ICS = Inhaled corticosteroids

VC = Vital capacity

IC = Inspiratory capacity

FVC = Forced vital capacity

FEV1 = Maximal expiratory volume in the first second

FRC = Functional residual capacity

TLC = Total lung capacity

RV = Residual volume

CPExT = Cardiopulmonary exercise test

EILV = End-inspiratory lung volume

EELV = End-expiratory lung volume

DH = Dynamic hyperinflation

FEF25-75% = Expiratory flow-rate between 25% and 75% of forced vital capacity

Ethics approval and consent to participate

The study was performed in accordance with the Helsinki declaration and was approved by the local University-Hospital Ethic Committee.

Consent for publication

All the study’s participants signed a Written Informed Consent

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Conflicts of interest/Competing interests

MS: reports no conflicts of interest in this work;

LP: reports no conflicts of interest or competing interests in this work;

FQ: reports no conflicts of interest or competing interests in this work;

FS: reports no conflicts of interest or competing interests in this work;

DB: reports no conflicts of interest or competing interests in this work;

CT: reports no conflicts of interest or competing interests in this work;

Funding

Not applicable

Authors’ contributions

CT and MS: Study design

MS, FS, FQ, and LP: Data collection

LP, DB, and FS: Data Analysis

All authors: Interpretation of results

CT: Initial draft

All authors: Review of the manuscript for intellectual content

Acknowledgements

The Authors acknowledge Mr. M. Guerini, Lab. technician, for his invaluable technical support.

Weiler JM, Anderson SD, Randolph C, et al. Pathogenesis, prevalence, diagnosis and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010;105 (suppl):S1-S47.
Couto M, Kurowski M, Moreira A et al. Mechanism of exercise-induced bronchoconstriction in athletes: Current prospective and future challenges. Allergy 2018; 73:8-16.
Randolph CC, Dreyfus D, Rundell KW, Bangladore D, Fraser, B. Prevalence of allergy and asthma symptoms in recreational roadrunners. Med Sci Sports Exerc 2006; 38:2053-2057.
Cabral AL, Conceiçao GM, Fonseca-Guedes CH, Martins MA. Exercise-induced bronchospasm in children: effects of asthma severity. Am J Respir Crit. Care Med 1999; 159:1819-1823.
Weiler JM, Bonini S, Coifman R et al. American Academy of Allergy, Asthma & Immunology work group report: exercise-induced asthma. J All Clin Immunol 2007;119:1349-1358.
Boulet L-P and O’Byrne P. Asthma and exercise-induced bronchoconstriction in athletes. New Engl J Med 2015; 372:641-648.
Anderson SD, Kippelen P. Exercise-induced bronchoconstriction: pathogenesis. Curr Allergy Asthma Rep 2005; 5:116-122.
Mc Fadden ER Jr. Exercise-induced airway obstruction. Clin Chest Med 1995; 16:671-682.
Suman OE, Babock MA, Pegelow DF et al. Airway obstruction during exercise in asthma. Am J Respir Crit Care Med. 1995; 152:24-31.
Smoliga JM, Weiss P, Rundell KW. Exercise-induced bronchoconstriction in adults: evidence based diagnosis and management: BMJ 2016; 352:1-8.
Global Initiative for Asthma - Global Strategy for Asthma management and prevention, updated 2019. Available from https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report -June-2019-wms.pdf. Accessed September 24, 2020.
Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26:153-1611.
Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Eur Respir J 1993; 6 Suppl 16:5-40.
Downie SR, Salome CM, Verbanck S et al. Ventilation heterogeneity is a major determinant of the airway responsiveness in asthma, independent of airway inflammation. Thorax 2007; 62:684-689.
Kosmas EN, Milic-Emii J, Polychronaki A et al. Exercise-induced flow limitation, dynamic hyperinflation and exercise capacity in patients with bronchial asthma. Eur Respir J 2004; 24:378-384.
Beck KC, Offord KP, Scanlon PD. Bronchoconstriction occurring during exercise in asthmatic subjects. Am J Respir Crit Care Med 1994; 149:352-357.
Jonhson BD, Scanlon PD, Beck KC. Regulation of ventilatory capacity during exercise in asthmatics. J Appl Physiol 1995; 79:892-901.
Cypcar D, Lemanske RF jr. Asthma and exercise. Clin Chest Med 1994; 15:351-368.
Tantucci C, Ellaffi M, Duguet A et al. Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma. Eur Respir J 1999; 14:295-301.
Oosteveen E, MacLeod D, Lorino H et al. The forced oscillation technique in clinical practice: methodology, recommendations, and future development. Eur Respir J 2003; 22:1026-1041.

Due to technical limitations the Tables are available as a download in the Supplementary Files.

Tables.pdf

Download PDF

Journal Publication

published 14 Aug, 2021

Read the published version in Allergy, Asthma & Clinical Immunology →

Editor assigned by journal
15 Mar, 2021
Submission checks completed at journal
15 Mar, 2021
Editor invited by journal
15 Mar, 2021
First submitted to journal
15 Mar, 2021

You are reading this latest preprint version

Predictors of exercise-induced bronchoconstriction in subjects with mild asthma

Status:

Journal Publication

Version 2

Abstract

Figures

Background

Methods

Results

Discussion

Conclusions

List Of Abbreviations

Declarations

References

Tables

Supplementary Files

Status:

Journal Publication

Version 2